Harvard Bioscience Inc. (HBIO) rose 7.1% or 0.22 to $3.4. It is nearly 77877 shares traded, which is 93.98% compare to the average total volume 82867. The market cap of HBIO is $126.61 million. The year to date change is 6.16%. The 52 week price range is from $2.96 to $6.7. Price of HBIO have changed -4.80% during last week. It have changed -3.35% over last month, -30.79% over last 3 months, -38.45% over last 6 months and -19.75% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HBIO is 3.60. It is 5.88% above current price. The 200-day Moving Averages for HBIO is 4.84. It is 42.35% above current price. The 52-week High is 6.7. It is 97.06% from the current price. The 52-week Low is 2.96. It is -12.94% from current price.
There are some statistics of HBIO. It is has market cap $126.61 million. The share outstanding is 37.29 million. The average volume is 82867. The percent of top 15 Institution holding is 96.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HBIO is -6.06%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HBIO is -3.47%.